Who Exports Herbal from India — 320 Suppliers Behind a $18.9M Market
India's herbal export market is supplied by 320 active exporters who collectively shipped $18.9M across 15,000 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 18.8% market share, followed by EMAMI LIMITED and SURYA HERBAL LIMITED. The top 5 suppliers together control 38.0% of total export value, reflecting a moderately competitive market structure.

Top Herbal Exporters from India — Ranked by Export Value
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading herbal exporter from India, holding a 18.8% share of the $18.9M market across 15,000 shipments from 320 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, EMAMI LIMITED, SURYA HERBAL LIMITED, JANGIR EXPORTS, J B CHEMICALS AND PHARMACEUTICALS LIMITED — collectively control 38.0% of total export value, indicating a competitive market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (18.8%), EMAMI LIMITED (6.4%), SURYA HERBAL LIMITED (6.3%), JANGIR EXPORTS (3.4%), J B CHEMICALS AND PHARMACEUTICALS LIMITED (3.1%).
Top Herbal Exporters from India
Ranked by export value · 320 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED DOKTOR MOM HERBAL COUGH SYRUP 150MLNEOTRAVISIL HERBAL LOZENGES MINT NEOTRAVASSORTED HERBAL VET ITEMS(ITEM NO:58 TO | $3.5M | 4 | 18.8% |
| 2 | EMAMI LIMITED DOKTOR MOM HERBAL COUGH SYRUP 150MLNEOTRAVISIL HERBAL LOZENGES MINT NEOTRAVHIMANI FAST RELIEF HERBAL PAIN RELIEF OI | $1.2M | 10 | 6.4% |
| 3 | SURYA HERBAL LIMITED NIKVORM PET BOTTLE - 60 ML HERBAL COHERBAL BLEND ZKDCENSTON ) (HERBAL COM | $1.2M | 5 | 6.3% |
| 4 | JANGIR EXPORTS AYURVEDIC/HERBAL- NEEM TAB 60 SAYURVEDIC/HERBAL- SPEMAN TAB 60 SAYURVEDIC/HERBAL- TRIPHALA TAB 60 S | $640.6K | 1 | 3.4% |
| 5 | J B CHEMICALS AND PHARMACEUTICALS LIMITED DOKTOR MOM HERBAL COUGH SYRUP 150MLNEOTRAVISIL HERBAL LOZENGES MINT NEOTRAVHIMANI FAST RELIEF HERBAL PAIN RELIEF OI | $578.7K | 10 | 3.1% |
| 6 | HISHIMO PHARMACEUTICALS PRIVATE LIMITED NIKVORM PET BOTTLE - 60 ML HERBAL COCENSTON ) (HERBAL COMCENSTON-F (HERBAL CO | $552.0K | 1 | 2.9% |
| 7 | MARION BIOTECH PRIVATE LIMITED TRAVAMAX PLUS HERBAL GRANULES:TRAVRELAX HERBAL GRANULES. O/D AS PER IN | $489.9K | 3 | 2.6% |
| 8 | ADARSH INTERNATIONAL | $469.7K | 1 | 2.5% |
| 9 | SACRED LEAVES PRIVATE LIMITED HERBAL PRODUCT OF INDIAN ORIGIN ITEM- BRHERBAL PRODUCT OF INDIAN ORIGIN ITEM - BAYURVEDIC/HERBAL- NEEM TAB 60 S | $457.4K | 4 | 2.4% |
| 10 | DALMIA HEALTHCARE LIMITED NIKVORM PET BOTTLE - 60 ML HERBAL COCENSTON ) (HERBAL COMHERBALFORMULATIONS ASTHA- 15 CAPSULE | $372.7K | 1 | 2.0% |
| 11 | COMBITIC GLOBAL CAPLET PRIVATE LIMITED HERBAL PRODUCT OF INDIAN ORIGIN ITEM- BRHERBAL PRODUCT OF INDIAN ORIGIN ITEM - BAYURVEDIC/HERBAL- NEEM TAB 60 S | $333.1K | 2 | 1.8% |
| 12 | KARNANI PHARMACEUTICALS PVT LTD DOKTOR MOM HERBAL COUGH SYRUP 150MLNEOTRAVISIL HERBAL LOZENGES MINT NEOTRAVNEOTRAVISIL HERBAL LOZENGES HONEY-LEMON | $331.4K | 1 | 1.8% |
| 13 | YUVANSH INTERNATIONAL HERBAL PRODUCT OF INDIAN ORIGIN ITEM- BRHERBAL PRODUCT OF INDIAN ORIGIN ITEM - BBRONCHO VEDA, HERBAL LOZENGES WITH ORANGE FLAVOUR NO 12X2 | $327.1K | 2 | 1.7% |
| 14 | CHARAK PHARMA PRIVATE LIMITED HIMANI FAST RELIEF HERBAL PAIN RELIEF OIASSORTED HERBAL VET ITEMS(ITEM NO:58 TOSIDDHA MEDICINE ( COFSIL HERBAL COUGH SY | $319.5K | 13 | 1.7% |
| 15 | AMOL PHARMACEUTICALS PRIVATE LIMITED HERBAL MEDICAMENTS CURCUHERB 85% GRANULESKGSHERBAL MEDICAMENTS CURCUHERB 85% GRANULESHERBAL MEDICAMENTS- CURCUHERB 85% GRANULES, | $316.3K | 1 | 1.7% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Herbal exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Warning Letter, June 2024 | Yes, as of August 20 | Yes | Not verified | Received FDA warning letter for CGMP violations; holds WHO-GMP and EU GMP certif |
| J B Chemicals and Pharmaceuticals Limited | Approved | Yes, as of August 20 | Yes | Not verified | FDA-approved; holds WHO-GMP and EU GMP certifications. |
| Marion Biotech Private Limited | Not Listed | Yes, as of August 20 | Yes | Not verified | Holds WHO-GMP and EU GMP certifications; no FDA listing found. |
| Charak Pharma Private Limited | Not Listed | Yes, as of August 20 | Yes | Not verified | Holds WHO-GMP and EU GMP certifications; no FDA listing found. |
| Amol Pharmaceuticals Private Limited | Not Listed | Yes, as of August 20 | Yes | Not verified | Holds WHO-GMP and EU GMP certifications; no FDA listing found. |
TransData Nexus reviewed the regulatory standing of 5 leading Herbal exporters from India. 1 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 5 are EU GMP compliant. 1 supplier has received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Herbal sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for pharmaceutical manufacturing, including herbal medicines. The city's pharmaceutical ecosystem is bolstered by the presence of numerous manufacturing facilities, research institutions, and a skilled workforce. The establishment of Hyderabad Pharma City has further enhanced its capacity, focusing on biotech drugs, vaccines, and research and development activities. This infrastructure supports the production of high-quality herbal formulations, contributing significantly to India's herbal exports.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. This region hosts several leading pharmaceutical companies specializing in the production of various drug formulations, including herbal medicines. The presence of state-of-the-art manufacturing facilities and a robust supply chain infrastructure makes this cluster a key player in the herbal pharmaceutical sector. Companies like Alembic Pharmaceuticals, headquartered in Vadodara, exemplify the region's prominence in pharmaceutical manufacturing.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a crucial export gateway for India's pharmaceutical products, including herbal medicines. Mumbai's strategic location with access to major ports facilitates efficient international distribution. The region's well-established pharmaceutical industry, combined with robust logistics and regulatory frameworks, ensures the seamless export of herbal products to global markets. This cluster's capabilities are instrumental in maintaining India's position as a leading exporter of herbal medicines.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi and Nalagarh in Himachal Pradesh have emerged as significant pharmaceutical manufacturing hubs, partly due to favorable tax incentives offered by the government. These incentives have attracted numerous pharmaceutical companies to set up manufacturing units in the region, including those producing herbal medicines. The clean environment and pollution-free zones further enhance the quality of herbal product manufacturing in this cluster.
5Sourcing Recommendations
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and quality standards of suppliers in key clusters such as Hyderabad, Ahmedabad-Vadodara, Mumbai-Thane-Raigad, and Baddi-Nalagarh to ensure they meet international regulatory requirements.
- Leverage Export Infrastructure: Utilize the export facilities and logistical advantages offered by the Mumbai-Thane-Raigad region to streamline the distribution of herbal products to international markets.
- Monitor Regulatory Compliance: Stay updated on the regulatory frameworks governing herbal medicine exports, particularly those outlined by the Directorate General of Foreign Trade (DGFT) and the Central Drugs Standard Control Organisation (CDSCO), to ensure compliance and avoid potential trade barriers.
- Diversify Export Markets: Given that Russia, Kazakhstan, Algeria, the United Arab Emirates, and Uzbekistan account for significant portions of India's herbal product exports, consider exploring emerging markets to reduce dependency on a few countries and mitigate geopolitical risks.
By strategically engaging with these pharmaceutical clusters and adhering to regulatory standards, stakeholders can effectively source and export high-quality herbal products from India.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Herbal exporters from India
SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires Concert Pharmaceuticals for $355 million
Sun Pharmaceutical Industries Limited completed the acquisition of Concert Pharmaceuticals, Inc., a U.S.-based biotechnology company specializing in immunotherapy and targeted oncology treatments, for $355 million. IMPACT: This acquisition is expected to enhance Sun Pharma's research capabilities, potentially leading to the development of new herbal-based therapies and expanding their herbal product portfolio.
Impact: This acquisition is expected to enhance Sun Pharma's research capabilities, potentially leading to the development of new herbal-based therapies and expanding their herbal product portfolio.
SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma merges with Taro Pharmaceuticals in $347.73 million deal
Sun Pharmaceutical Industries Limited entered into a definitive merger agreement with Taro Pharmaceutical Industries Ltd., acquiring the remaining stake for $347.73 million. IMPACT: The merger is anticipated to strengthen Sun Pharma's global distribution channels, potentially increasing the reach of their herbal products in international markets.
Impact: The merger is anticipated to strengthen Sun Pharma's global distribution channels, potentially increasing the reach of their herbal products in international markets.
SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma partners with Pharmazz for ischemic stroke drug in India
Sun Pharmaceutical Industries Limited entered into a licensing agreement with Pharmazz Inc. to introduce an ischemic stroke drug in India. IMPACT: While focused on ischemic stroke treatment, this collaboration may lead to further research and development in herbal-based pharmaceuticals, potentially diversifying Sun Pharma's herbal product offerings.
Impact: While focused on ischemic stroke treatment, this collaboration may lead to further research and development in herbal-based pharmaceuticals, potentially diversifying Sun Pharma's herbal product offerings.
Common Questions — Herbal Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which herbal supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 63 recorded shipments worth $3.5M. EMAMI LIMITED (78 shipments) and SURYA HERBAL LIMITED (62 shipments) are also established high-volume exporters.
Q How many herbal manufacturers are there in India?
India has 320 active herbal exporters with a combined export market of $18.9M across 15,000 shipments to 115 countries. The top 5 suppliers hold 38.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for herbal from India?
Average FOB unit price: $5.40 per unit, ranging from $0.01 to $2384.63. Average shipment value: $1.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 320 verified Indian exporters of Herbal ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 115 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
320 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists